重回正轨以实现全球贫血减少目标:一项《柳叶刀-血液病学》委员会报告
该委员会从数据、病因与管理、实施与治理及目标设定四方面提出建议,并基于卫生经济学模型提出全球贫血患病率降低12–22%的初步目标,显著低于现行50%目标。
要点
- 呼吁建立标准化全球数据仓库和统一微量营养素调查平台,并将血红蛋白评估纳入现有静脉采血调查平台。
- 贫血病因复杂,涉及铁缺乏、其他微量营养素缺乏、感染、炎症、失血和遗传性血液病,需针对性研究和综合干预。
- 现行50%贫血减少目标未充分纳入国家情境、关注总体患病率而非疾病负担且幅度不可实现,建议采用循证目标设定框架。
核心结论
- 减轻贫血负担需采取综合、多部门方法,考虑其复杂病因和在不同人群中的不同影响。
- 通过采纳本委员会提出的改进数据系统、更有针对性的研究、整合项目执行和循证目标设定等建议,全球卫生界可重振贫血减少势头。
- 实现进展需要持续政治承诺、增加投资以及政府、国际机构、民间社会和研究者的协调行动。
研究设计与样本
- 本报告为《柳叶刀-血液病学》委员会报告,旨在通过解决数据、证据、实施、治理和目标设定方法的关键差距,重振贫血预防和控制工作。
- 委员会批判性评估了2030年贫血目标的设定过程,并提出一种更循证、因地制宜的目标设定框架。
主要发现
- 许多国家缺乏可靠的贫血患病率数据,尤其是幼儿和育龄妇女以外的人群,且少有国家调查同时测量贫血及其根本原因。
- 现行50%贫血减少目标的关键局限包括:未清晰考虑国家特定情境、关注贫血总体患病率而非贫血疾病负担、以及即使最大化部署现有干预措施也无法实现的幅度目标。
- 基于卫生经济建模的新目标设定框架初步应用提示,全球贫血患病率降低的汇总目标为12–22%,显著低于当前50%目标,且国家特定目标差异显著。
关键数值与推荐
- 建议创建标准化全球数据仓库,开发统一微量营养素调查平台,以收集全面、周期性数据。
- 建议更好地整合家庭调查和其他卫生数据来源等不同来源的数据,并将血红蛋白评估纳入已收集静脉血的现有调查平台。
- 建议开展针对性研究以阐明潜在机制、改进贫血决定因素评估工具、推进营养干预,并将感染控制与营养项目整合。
- 有效实施贫血减少项目的关键建议包括:在全球、国家和国家以下层面建立清晰治理结构;扩大国家营养计划以纳入跨部门协调和贫血相关策略的高效管理;将社会公平和基本人权置于贫血重点政策和干预的中心。
- 提出基于卫生经济建模的新型目标设定框架,纳入国家贫血患病率、当前干预覆盖率和效果、潜在扩大成本及一系列潜在国家特定成本效果阈值。
临床怎么用
- 委员会建议持续提供财政支持并协调人口与健康调查,尤其考虑到美国全球数据倡议资金可能减少。
- 委员会建议优化铁剂剂量和剂型、有效组合微量营养素、改进强化和生物强化策略,并评估延迟脐带结扎和感染控制等非营养干预以及月经过多和产后出血管理。
- 委员会强调需要解决导致贫血的环境因素,如空气污染和气候变化。
- 委员会主张采用参与式、迭代式目标设定过程,与当地优先事项和资源保持一致。
局限性
- 现行50%贫血减少目标未清晰考虑国家特定情境。
- 现行50%贫血减少目标关注贫血总体患病率而非贫血疾病负担。
- 现行50%贫血减少目标的幅度即使最大化部署现有干预措施也无法实现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
GLOBAL BURDEN AND DATA GAPS: Many countries lack reliable data on anaemia prevalence, especially for populations beyond young children and women of reproductive age. Few national surveys measure both anaemia and its underlying causes. We call for the creation of a standardised global data repository and the development of a harmonised micronutrient survey platform to collect comprehensive, periodic data. We also recommend better integration of data across sources, including household surveys and other health data sources, and inclusion of haemoglobin assessment in existing survey platforms that already collect venous blood. Continued financial support and coordination of demographic and health surveys are crucial, especially in light of potential reductions in U.S. funding for global data initiatives. ANAEMIA AETIOLOGY AND MANAGEMENT: The causes of anaemia are multifactorial including iron deficiency, other micronutrient deficiencies, infections, inflammation, blood loss, and inherited blood disorders. We identify critical knowledge gaps in the complex interactions between these risk factors across life stages in different populations. We recommend targeted research to elucidate underlying mechanisms, improved tools for assessing anaemia determinants, advanced nutritional interventions, and integration of infection control with nutrition programs. Specific areas highlighted for further research include optimising iron dosing and formulations, effective combinations of micronutrients, improving fortification and biofortification strategies, and evaluating non-nutritional interventions such as delayed cord clamping and infection control, and management of heavy menstrual bleeding and post-partum haemorrhage. We also emphasise the need to address environmental factors contributing to anaemia, such as air pollution and climate change. IMPLEMENTATION AND GOVERNANCE: Effective implementation of anaemia control programs requires tailored, multi-sectorial strategies and ongoing monitoring. Our key recommendations for effective implementation of anaemia reduction programmes are: (1) developing clear governance structures at global, national and sub-national levels to ensure proper oversight and accountability; (2) broadening national nutrition plans to incorporate cross-sector coordination and efficient management of anaemia-related strategies, and (3) placing social equity and fundamental human rights at the centre of anaemia-focused policies and interventions. REDEFINING FUTURE ANAEMIA REDUCTION TARGETS: This Commission critically evaluates the process by which the 2030 anaemia targets were set and proposes a more evidence-based, context-specific approach. Key limitations of the current 50% anaemia reduction target are: (1) not clearly accounting for country-specific contexts; (2) focussing on overall prevalence of anaemia rather than anaemia disease burden; and (3) a reduction target for magnitude that was unachievable using available interventions even if maximally deployed. We proposed a novel target-setting framework based on health economic modelling. This approach incorporates national anaemia prevalence, current intervention coverage and effectiveness, potential scale-up costs, and a range of potential country-specific cost-effectiveness thresholds. This approach aims to balance ambition with achievability while maintaining a unified global vision. Preliminary application of this method suggests a global summary target of 12–22% reduction in anaemia prevalence, significantly lower than the current 50% target, with marked variation in country-specific targets. We advocate for a participatory, iterative target-setting process aligning with local priorities and resources. CONCLUSION: Reducing the burden of anaemia requires a comprehensive, multi-sectorial approach that considers its complex aetiology and varied impacts across populations. By adopting the recommendations outlined in this Commission—including improved data systems, more targeted research, integrated programme implementation, and evidence-based target-setting—the global health community can renew momentum toward meaningful anaemia reduction. Achieving progress will require sustained political commitment, increased investment, and coordinated action from governments, international agencies, civil society, and researchers. As the global health agenda evolves beyond the 2030 Sustainable Development Goals, the insights and strategies presented in this Commission offer a roadmap for a more effective, equitable, and sustainable approach to tackling anaemia worldwide. Anaemia, a condition affecting over 1.9 billion people worldwide, disproportionately impacts children, adolescent girls and women. Despite longstanding interventions and guidelines, most countries remain off-track to meet global anaemia reduction targets, and recent cuts in global health funding further threaten progress. This Lancet Haematology Commission aims to reinvigorate efforts to prevent and control anaemia by addressing key gaps in data, evidence, implementation, governance, and target-setting approaches.
引用
- Atkinson SH, Suchdev PS, Bode M, et al. Getting back on track to meet global anaemia reduction targets: a Lancet Haematology Commission. Lancet Haematol. 2025. PMID: 40882649. doi:10.1016/S2352-3026(25)00146-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。